Renalytix AI PLC Holding(s) in Company (5461G)
November 26 2020 - 1:01AM
UK Regulatory
TIDMRENX TIDMEKF
RNS Number : 5461G
Renalytix AI PLC
26 November 2020
TR-1: S tandard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible) (i)
1a. Identity of the issuer or the Renalytix AI Plc
underlying issuer of existing shares 213800NTOH3FK3WER551
to which voting rights are attached
(ii) :
---------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
---
2. Reason for the notification (please mark the appropriate box or
boxes with an "X")
An acquisition or disposal of voting rights X
---
An acquisition or disposal of financial instruments
---
An event changing the breakdown of voting rights
---
Other (please specify)(iii) :
---
3. Details of person subject to the notification obligation (iv)
Name
EKF Diagnostics Holdings Plc
City and country of registered office Avon House, 19 Stanwell Road, Penarth,
(if applicable) Cardiff, CF64 2EZ
4. Full name of shareholder(s) (if different from 3.) (v)
Name
---------------------------------------------
City and country of registered office
(if applicable)
---------------------------------------------
5. Date on which the threshold was
crossed or reached (vi) : 24 November 2020
---------------------------------------------
6. Date on which issuer notified (DD/MM/YYYY):
25 November 2020
---------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting
to shares (total instruments 8.B) rights of
of 8. A) (total of 8.B issuer (vii)
1 + 8.B 2)
------------------ ---------------------- ---------------- ------------------
Resulting situation
on the date
on which threshold
was crossed
or reached Below 3% - Below 3% 72,029,634
------------------ ---------------------- ---------------- ------------------
Position of
previous notification
(if
applicable) 3.72% - 3.72%
------------------ ---------------------- ---------------- ------------------
8. Notified details of the resulting situation on the date on which
the threshold was crossed or reached (viii)
A: Voting rights attached to shares
Class/type of Number of voting rights % of voting rights
shares (ix)
ISIN code (if
possible)
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.2.1)
--------------------------
GB00BYWL4Y04 Below 3% - Below 3% -
----------------------- -------------------------- ------------------------- ---------------------
SUBTOTAL 8. A Below 3% Below 3%
--------------------------------------------------- ------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
(DTR5.3.1.1 (a))
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion Period rights that may rights
instrument (x) (xi) be acquired if
the instrument
is
exercised/converted.
------------ ------------------------------ -------------------------------- ---------------------
SUBTOTAL 8. B 1
------------------------------ -------------------------------- ---------------------
B 2: Financial Instruments with similar economic effect according to
Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of Expiration Exercise/ Physical or Number of % of voting
financial date (x) Conversion cash voting rights rights
instrument Period (xi) settlement
(xii)
---------------- -------------------- -------------------- --------------------
SUBTOTAL 8.B.2
-------------------- --------------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled
by any natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the
(underlying) issuer (xiii)
Full chain of controlled undertakings through which the voting rights x
and/or the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entity (xiv) (please add additional
rows as necessary)
Name (xv) % of voting rights % of voting rights Total of both if
if it equals or through financial it equals or is
is higher than the instruments if it higher than the
notifiable threshold equals or is higher notifiable threshold
than the notifiable
threshold
---------------------- --------------------- ------------------------
EKF Diagnostics Below 3% Below 3%
Holdings Plc (Direct/Indirect)
---------------------- --------------------- ------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder N/A
-----------------------------------------------
The number and % of voting rights N/A
held
-----------------------------------------------
The date until which the voting rights N/A
will be held
-----------------------------------------------
11. Additional information (xvi)
Notification using the total voting rights figure of 72,029,634
Place of completion London Stock Exchange
Date of completion 25/11/2020
----------------------
, the news service of the London Stock Exchange. RNS is approved by
the Financial Conduct Authority to act as a Primary Information
Provider in the United Kingdom. Terms and conditions relating to
the use and distribution of this information may apply. For further
information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLFZMZMMKFGGZZ
(END) Dow Jones Newswires
November 26, 2020 02:01 ET (07:01 GMT)
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Apr 2023 to Apr 2024
